Article info

Download PDFPDF

Original research
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

Authors

  • Michaela Koehm Department of Rheumatology, Goethe University, Frankfurt am Main, GermanyFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyFraunhofer Cluster of Excellence Immune-mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Maximilian Klippstein Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyFraunhofer Cluster of Excellence Immune-mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Stephanie Dauth Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyFraunhofer Cluster of Excellence Immune-mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Konstantin Hallmann Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyFraunhofer Cluster of Excellence Immune-mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Niko Kohmer Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Harald Burkhardt Department of Rheumatology, Goethe University, Frankfurt am Main, GermanyFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyFraunhofer Cluster of Excellence Immune-mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Sandra Ciesek Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyInstitute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, GermanyVirology, German Centre for Infection Research, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Gerd Geisslinger Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyFraunhofer Cluster of Excellence Immune-mediated Diseases CIMD, Frankfurt am Main, GermanyPharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, Goethe University, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Holger F Rabenau Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Frank Behrens Department of Rheumatology, Goethe University, Frankfurt am Main, GermanyFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyFraunhofer Cluster of Excellence Immune-mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Frank Behrens; Frank.Behrens{at}itmp.fraunhofer.de
View Full Text

Citation

Koehm M, Klippstein M, Dauth S, et al
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

Publication history

  • Received February 21, 2023
  • Accepted June 23, 2023
  • First published August 31, 2023.
Online issue publication 
August 31, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.